Cargando...
Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential
The growth factor-like lipid mediator, lysophosphatidic acid (LPA), is a potent signaling molecule that influences numerous physiologic and pathologic processes. Manipulation of LPA signaling is of growing pharmacotherapeutic interest, especially because LPA resembles compounds with drug-like featur...
Gardado en:
| Publicado en: | J Lipid Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The American Society for Biochemistry and Molecular Biology
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6399510/ https://ncbi.nlm.nih.gov/pubmed/30692142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.S091744 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|